CDG2E: A Promising Drug Target and Biomarker for Various Diseases

Target Name: COG7

NCBI ID: G91949

COG7

CDG2E: A Promising Drug Target and Biomarker for Various Diseases

COG7, also known as CDG2E, is a protein that is expressed in various tissues throughout the body. Its primary function is to interact with the protein T-cell receptor (TCR), which is a critical receptor for regulating immune responses. CDG2E has been identified as a potential drug target and a biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

The discovery of CDG2E as a potential drug target stems from its unique structure and its ability to interact with multiple proteins, including TCR. \"Our studies have shown that CDG2E can form a complex with the TCR, and that this interaction is critical for its function,\" said Dr. Xinran Li, a leading researcher at the University of California, San Diego. \"We believe that CDG2E could be a promising drug target for a variety of diseases.\"

CDG2E's ability to interact with TCR has important implications for the development of cancer therapies. Many cancer therapies work by targeting TCR, with drugs such as checkpoint inhibitors and adoptive T cell therapy being examples. By targeting CDG2E, these therapies could be improved or reduced in their effectiveness.

In addition to its potential as a drug target, CDG2E has also been identified as a biomarker for various diseases. Its expression has been observed in a variety of tissues, including cancer, brain, and heart tissues. This suggests that CDG2E may serve as a useful biomarker for disease diagnosis and monitoring. \"Our studies have shown that CDG2E is expressed in a variety of tissues and that it is closely associated with the development of certain diseases,\" said Dr. Li. \"We believe that these findings could be the basis for the development of new diagnostic tests or therapies.\"

CDG2E's potential as a drug target and biomarker make it an attractive target for research into the development of new therapies for a variety of diseases. As the field of pharmacology continues to evolve, the study of CDG2E and its potential applications will undoubtedly be a crucial part of this progress.

Protein Name: Component Of Oligomeric Golgi Complex 7

Functions: Required for normal Golgi function

The "COG7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COG7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets